http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1044971-A4

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1394e66eb648f9bf0a1f5507fe25b67b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D305-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D305-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
filingDate 1998-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4907ee2d1ad8c4e62562bf5c06805da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_791b8eb46540ec87ded81845658bd3b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28a196231f8b0671420822e6c972e1f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22fac4ca52bac08cfdc81638a568bb64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddfe9115563f9a79bf0cabbfcc03beb9
publicationDate 2001-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1044971-A4
titleOfInvention TAXANE DERIVATIVES
abstract Taxane derivatives represented by general formula (1) or salts thereof and drugs containing the same as the active ingredient wherein A1 represents (a) (wherein R1 represents H or optionally substituted alkyl) or (b) (wherein R2 represents amino, mono- or dialkylamino, piperidino, pyrrolidino or morpholino); X represents H, alkoxycarbonyl or benzoyl; Y represents H or trialkylsilyl; A2 represents furyl, alkylfuryl, alkyl or fluorophenyl; Ac represents acetyl; and Bz represents benzoyl. These compounds are excellent in solubility in water and antitumor activity.
priorityDate 1997-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1022277-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0534708-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0524093-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0534709-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457472442
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394823
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID240
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393570
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401

Total number of triples: 40.